| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/08/2003 | US20030086914 Method and device for inducing biological processes by micro-organs |
| 05/08/2003 | US20030086913 For therapy of tumors and cancer |
| 05/08/2003 | US20030086912 Antisense modulation of microsomal triglyceride transfer protein expression |
| 05/08/2003 | US20030086907 Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases |
| 05/08/2003 | US20030086906 Method of inducing an immune response using vaccinia virus recombinants |
| 05/08/2003 | US20030086904 Therapeutic regimen for treating cancer |
| 05/08/2003 | US20030086903 Therapeutic regimen for treating cancer |
| 05/08/2003 | US20030086871 Exposing eukaryotic organisms to a single fungal pathogen in the presence of at least one candidate compound; identifying a compound that inhibits fungal pathogen in each of eukaryotic organisms |
| 05/08/2003 | US20030086690 Storage medium having preloaded font information, and apparatus for and method of reproducing data from storage medium |
| 05/08/2003 | US20030085719 Micro-electrical detector on-chip |
| 05/08/2003 | US20030084515 Variant Endoglucanase III (EGIII) derived from Trichoderma reesei that has a substitution at a residue which is sensitive to surfactant and/or temperature stress; transformed host cells and vectors; use in detergents for example |
| 05/08/2003 | CA2821597A1 Promotion of somatic embryogenesis in plants by wuschel gene expression |
| 05/08/2003 | CA2756610A1 Methods for producing proteins having n-linked glycans comprising (sialyl-) lewis x or lacdinac structures |
| 05/08/2003 | CA2466129A1 Methods for genetically modifying a target population of an organism |
| 05/08/2003 | CA2465714A1 Isolated peptide of the hepatocyte growth factor and its variants, preparation method and therapeutic use as anti-angiogenic agents |
| 05/08/2003 | CA2465639A1 Tumor antigen |
| 05/08/2003 | CA2465402A1 Anthrax antigenic compositions |
| 05/08/2003 | CA2465367A1 Diagnosis and treatment of infectious diseases through indel-differentiated proteins |
| 05/08/2003 | CA2465353A1 Dna polymerase eta (pol.eta.) cdna and uses thereof |
| 05/08/2003 | CA2465320A1 Use of cbg gene as genetic marker of hypercortisolemia and related pathologies |
| 05/08/2003 | CA2465314A1 Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 05/08/2003 | CA2465129A1 Acyclic linker-containing oligonucleotides and uses thereof |
| 05/08/2003 | CA2465040A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 05/08/2003 | CA2465037A1 Genetic vaccine against human immunodeficiency virus |
| 05/08/2003 | CA2464995A1 Methods to treat diabetes and related conditions based on polymorphisms in the tcf1 gene |
| 05/08/2003 | CA2464956A1 Detection of haematopoietic stem cells and progeny and uses thereof |
| 05/08/2003 | CA2464940A1 Pyranosone dehydratase from phanerochaete chrysosporium |
| 05/08/2003 | CA2464887A1 Methods and compositions for treating parkinson's disease |
| 05/08/2003 | CA2464298A1 Fungal micro-organism having an increased ability to carry out biotechnological process(es) |
| 05/08/2003 | CA2464147A1 Promotion of somatic embryogenesis in plants by wuschel gene expression |
| 05/08/2003 | CA2463091A1 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 05/08/2003 | CA2462660A1 Nucleic acid-associated proteins |
| 05/08/2003 | CA2460283A1 Therapeutics and diagnostics for disorders of erythropoiesis |
| 05/08/2003 | CA2361462A1 Induction of tolerance to a therapeutic polypeptide |
| 05/07/2003 | EP1308727A1 Method of screening substance for preventing or treating diseases in association with il-6 family cytokine receptor malfunction |
| 05/07/2003 | EP1308517A1 Vectors for expressing multiple transgenes |
| 05/07/2003 | EP1308516A1 Site-directed recombinase fusion proteins and corresponding polynucleotides, vectors and kits, and their uses for site-directed DNA recombination |
| 05/07/2003 | EP1308515A2 Porcine factor VIII |
| 05/07/2003 | EP1308514A2 ICAM-4 Materials and Methods |
| 05/07/2003 | EP1308513A1 Use of polypeptide |
| 05/07/2003 | EP1308512A1 Novel proteins and dnas thereof |
| 05/07/2003 | EP1308511A1 Use of angiopoietin-like 1 and angiopoietin-like 2 nucleic acids and proteins for the treatment of blood-related disorders and defects in vasculature. |
| 05/07/2003 | EP1308510A1 Glycerylaldehyde-3-phosphate dehydrogenase promoter inducing cell death |
| 05/07/2003 | EP1308507A2 HCV anti-core monoclonal antibodies |
| 05/07/2003 | EP1308459A2 Full-length cDNA sequences |
| 05/07/2003 | EP1308092A1 Method of constructing gene manipulation animal and clone animal |
| 05/07/2003 | EP1307748A2 Assay method, peptides and reagent kits for testing mrp-specific inhibitors |
| 05/07/2003 | EP1307743A2 Colloid compositions for solid phase biomolecular analytical systems |
| 05/07/2003 | EP1307738A2 Cytological evaluation of breast duct epithelial cells retrieved by ductal lavage |
| 05/07/2003 | EP1307594A1 Association of sim2 with cancer |
| 05/07/2003 | EP1307592A2 Single-labeled oligonucleotide probes |
| 05/07/2003 | EP1307591A2 Cation mediated triplex hybridization assay |
| 05/07/2003 | EP1307589A2 Method for detecting mutations in nucleotide sequences |
| 05/07/2003 | EP1307588A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE AND USES THEREOF |
| 05/07/2003 | EP1307584A1 Methods of screening novel agents for use in cancer therapy and prevention |
| 05/07/2003 | EP1307582A2 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 05/07/2003 | EP1307579A2 Bio-intermediates for use in the chemical synthesis of polyketides |
| 05/07/2003 | EP1307578A2 Ascorbic acid production from yeasts |
| 05/07/2003 | EP1307574A2 Targeting through integrins |
| 05/07/2003 | EP1307573A2 Transduction of chondrocytes using adenoviral vectors |
| 05/07/2003 | EP1307572A2 Materials and methods for delivery and expression of heterologous dna in vertebrate cells |
| 05/07/2003 | EP1307571A1 Gene expression from the internal ribosome entry site (ires) of rhopalosiphum padi virus (rhpv) |
| 05/07/2003 | EP1307570A2 Methods for the controlled, automatic excision of heterologous dna from transgenic plants and dna-excising gene cassettes for use therein |
| 05/07/2003 | EP1307569A2 Preparation of a recombinant protein in a prokaryotic host cell by improved codon use |
| 05/07/2003 | EP1307568A2 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 05/07/2003 | EP1307567A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 05/07/2003 | EP1307566A2 Mitogen activated kinase |
| 05/07/2003 | EP1307565A2 Vaccination against host cell-associated herpesviruses |
| 05/07/2003 | EP1307564A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 05/07/2003 | EP1307563A1 Nucleotide sequences which code for the lysr2 gene |
| 05/07/2003 | EP1307562A1 Nucleotide sequences which code for the lysr3 gene |
| 05/07/2003 | EP1307561A2 Nucleic acids, with the aid of which plants having an altered metabolite content can be produced |
| 05/07/2003 | EP1307560A2 Schizophrenia related gene and protein |
| 05/07/2003 | EP1307559A2 Slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 05/07/2003 | EP1307558A2 Novel ebi-3-alt protein and nucleic acid molecules and uses therefor |
| 05/07/2003 | EP1307557A2 Endothelial cell expression patterns |
| 05/07/2003 | EP1307556A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 05/07/2003 | EP1307555A2 18610, a human transient receptor and uses thereof |
| 05/07/2003 | EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof |
| 05/07/2003 | EP1307553A2 Mammalian dna binding membrane-associated protein-encoding gene and uses |
| 05/07/2003 | EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF |
| 05/07/2003 | EP1307551A2 Human ion channels |
| 05/07/2003 | EP1307550A1 Human 7tm protein receptors and polynucleotides encoding the same |
| 05/07/2003 | EP1307548A2 Novel lipase genes |
| 05/07/2003 | EP1307547A2 Novel amylolytic enzyme extracted from bacillus sp. a 7-7 (dsm 12368) and washing and cleaning agents containing this novel amylolytic enzyme |
| 05/07/2003 | EP1307546A2 Ampk-related serine/threonine kinase, designated snark |
| 05/07/2003 | EP1307545A2 REGULATION OF HUMAN p78-LIKE SERINE/THREONINE KINASE |
| 05/07/2003 | EP1307544A2 32132, a fucosyltransferase family member and uses therefor |
| 05/07/2003 | EP1307539A2 Gene expression profile for kshv infection and methods for treating same |
| 05/07/2003 | EP1307537A1 Neospora caninum isolate |
| 05/07/2003 | EP1307489A2 G protein-coupled receptors |
| 05/07/2003 | EP1307488A2 A human calcium channel protein and uses thereof |
| 05/07/2003 | EP1307483A2 Iapl-3 a protein inhibitor of apoptosis proteins |
| 05/07/2003 | EP1307482A2 Two coloured fluorimetric protease assay |
| 05/07/2003 | EP1307481A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 05/07/2003 | EP1307480A2 Mutant trichosanthin |
| 05/07/2003 | EP1307479A2 Herbicide target genes and methods |
| 05/07/2003 | EP1307478A2 Novel nucleotide sequences coding for the luxr gene and a process for the production of l-amino acids |
| 05/07/2003 | EP1307474A2 Proton-translocating retinal protein |
| 05/07/2003 | EP1307472A1 Peptides capable of functioning as mimotopes for estradiol analytes |